Latest Antidepressant Stories

Drug associated with rapid antidepressant effect in largest clinical trial to date Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai. The antidepressant benefits of ketamine were seen within 24 hours, whereas traditional antidepressants can take days or weeks to demonstrate a...

Results Presented at 166th Annual American Psychiatric Association Meeting SAN FRANCISCO, May 18, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration (FDA) for the...

Lawyers will update judge about consolidated federal litigation involving hundreds of lawsuits claiming SSRI anti-depressant use allegedly caused birth defects. Free consultations about legal options are now available to consumers. San Diego, CA (PRWEB) May 17, 2013 http://www.resource4thepeople.com/defectivedrugs/zoloft.html Resource4thePeople today announced it is providing consumers its latest update about consolidated federal lawsuits* involving allegations that the use of Zoloft or...

NEW YORK, May 14, 2013 /PRNewswire/ -- Intra-Cellular Therapies, Inc. ("ITI"), a biopharmaceutical company focused on the development of therapeutics for CNS disorders, is pleased to announce the appointment of Professor Sir Michael Rawlins, MD, FRCP, FMedSci, to its board of directors. Sir Michael is an internationally respected figure in the field of drug safety, clinical effectiveness and cost effectiveness having been Chairman of the UK's National Institute for Clinical...

-- Arena to Receive $65 Million in Milestone Payments from Eisai -- SAN DIEGO, May 7, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ( )(pronounced BEL-VEEK) into Schedule IV of the Controlled Substances Act. The scheduling designation will be effective 30 days after tomorrow's expected publication in the Federal...

Certain types of anti-depressants have been linked to an increase in the risk of Clostridium difficile infection (CDI) finds a study in BioMed Central's open access journal BMC Medicine. Awareness of this link should improve identification and early treatment of CDI. CDI is one of the most common hospital acquired infections and is responsible for more than 7000 deaths annually in the USA alone. Several types of medications are thought to increase risk of CDI, including anti-depressants,...

April Flowers for redOrbit.com - Your Universe Online A new study from the Ann Arbor Veterans Health Administration (VA) Healthcare System and the University of Michigan reveals the US Food and Drug Administration’s (FDA) warning that high doses of citalopram, also known as Celexa, can cause potentially serious abnormal heart rhythms might be doing more harm than good. The FDA attached a warning to the antidepressant in 2011, based on data linking higher doses of the drug to...

The Rottenstein Law Group, which represents clients with claims for injuries and birth defects allegedly caused by selective serotonin reuptake inhibitor antidepressants (SSRIs) including Zoloft, is helping to publicize the results of a study showing an increased mortality rate during the perioperative period for patients who are on an SSRI. (PRWEB) May 01, 2013 The Rottenstein Law Group, which represents clients with claims for injuries and birth defects allegedly caused by selective...

A UCLA-led study of adolescents receiving treatment for methamphetamine dependence has found that girls are more likely to continue using the drug during treatment than boys, suggesting that new approaches are needed for treating meth abuse among teen girls. Results from the study, conducted by the UCLA Center for Behavioral and Addiction Medicine and the community-based substance abuse treatment program Behavioral Health Services Inc., are published in the April edition of the Journal of...

Surveyed U.S. Psychiatrists Expect to Prescribe Edivoxetine to 25 Percent of Their Patients with Treatment-Resistant Depression, According to a New Report from Decision Resources BURLINGTON, Mass., May 1, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a greater effect on depressive symptoms than current treatments is one of the greatest unmet needs in patients with...